retatrutide glp-1 gip glucagon triple agonist phase 3 2025 Dual and Gut Peptide Agonists on Retatrutide Obesity Triple Agonist Targeting

Use caution and individualize the dosage and administration based on the patient's age, weight, and medical condition

The use of non-sterile injection techniques in unregulated settings increases infection risk, including abscess formation or blood-borne virus transmission

1 It binds to skin cell receptors to enhance gene expression related to repair and renewal, reducing the activity of enzymes that degrade skin structural proteins with age, and helping restore the skins natural regeneration processes

Taking the capsules after meals enriched with healthy fats improves absorption due to the lipid nature of the formulation